CLINICAL_TRIALS
trial_result
· 2020-11-27
Clinical Trial Update: Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis [Phase 2]
Summary
A Phase 2 study evaluating effectiveness and safety in subjects with moderate to severe psoriasis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2020-11-27